|
Volumn 296, Issue 5577, 2002, Pages 2410-2413
|
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCIDENT PREVENTION;
CELLS;
ENZYMES;
GENES;
HOUSES;
IMMUNOLOGY;
TOXIC MATERIALS;
GENE THERAPY;
GENETIC ENGINEERING;
ADENOSINE DEAMINASE;
GENE;
GENETICS;
IMMUNE RESPONSE;
ARTICLE;
CASE REPORT;
CELL DIFFERENTIATION;
COMBINED IMMUNODEFICIENCY;
ENZYME REPLACEMENT;
GENE THERAPY;
GENE TRANSFER;
HEMATOPOIETIC STEM CELL;
HUMAN;
LYMPHOCYTE COUNT;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
ADENOSINE DEAMINASE;
ANIMALS;
B-LYMPHOCYTES;
BONE MARROW TRANSPLANTATION;
CELL DIFFERENTIATION;
CHILD, PRESCHOOL;
GENE THERAPY;
GENETIC VECTORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
IMMUNOGLOBULINS;
INFANT;
LEUKOCYTES;
LEUKOPOIESIS;
LYMPHOCYTE ACTIVATION;
MICE;
MICE, SCID;
RETROVIRIDAE;
SEVERE COMBINED IMMUNODEFICIENCY;
T-LYMPHOCYTES;
TRANSDUCTION, GENETIC;
TRANSPLANTATION CONDITIONING;
ADA;
|
EID: 0037189401
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1070104 Document Type: Article |
Times cited : (1014)
|
References (27)
|